Filed: 11/14/2024ACC: 0001420506-24-002416
📋 What this filing means
SILVERARC CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 71 equity positions with a total reported market value of $445.29M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
71
Positions
$445.29M
Total AUM (reported)
55.22M
Total Shares
Allocation by class
COM$328.17M73.7%
SPONSORED ADS$33.45M7.5%
COM PAR $.01$25.38M5.7%
COM NEW$23.35M5.2%
SHS$10.80M2.4%
COM STK$6.54M1.5%
CL A COM$6.27M1.4%
Portfolio Concentration
Top 3$95.13M21.4%
4–10$113.99M25.6%
11–25$126.23M28.3%
Rest$109.94M24.7%
Top 3 weight
21.4%
Top 10 weight
47.0%
Voting Authority Distribution
Total shares with voting rights: 55.22M
Sole
Full voting authority
55.22M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole71
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings71
Rows:
NUVALENT INC
SOLEShares371.44K
TypeSH
Market value$38.00M
8.53%
Sole
371.44K
Shared
0.00
None
0.00
MERUS N V
SOLEShares635.44K
TypeSH
Market value$31.75M
7.13%
Sole
635.44K
Shared
0.00
None
0.00
INSMED INC
SOLEShares347.69K
TypeSH
Market value$25.38M
5.70%
Sole
347.69K
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
SOLEShares475.56K
TypeSH
Market value$21.84M
4.91%
Sole
475.56K
Shared
0.00
None
0.00
ERASCA INC
SOLEShares6.95M
TypeSH
Market value$18.96M
4.26%
Sole
6.95M
Shared
0.00
None
0.00
AKERO THERAPEUTICS INC
SOLEShares639.84K
TypeSH
Market value$18.36M
4.12%
Sole
639.84K
Shared
0.00
None
0.00
VERACYTE INC
SOLEShares470.56K
TypeSH
Market value$16.02M
3.60%
Sole
470.56K
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
SOLEShares255.58K
TypeSH
Market value$13.39M
3.01%
Sole
255.58K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares1.22M
TypeSH
Market value$13.19M
2.96%
Sole
1.22M
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares167.11K
TypeSH
Market value$12.23M
2.75%
Sole
167.11K
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares744.59K
TypeSH
Market value$11.91M
2.67%
Sole
744.59K
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares901.13K
TypeSH
Market value$11.44M
2.57%
Sole
901.13K
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares1.10M
TypeSH
Market value$11.27M
2.53%
Sole
1.10M
Shared
0.00
None
0.00
POSEIDA THERAPEUTICS INC
SOLEShares3.69M
TypeSH
Market value$10.55M
2.37%
Sole
3.69M
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares348.87K
TypeSH
Market value$10.04M
2.25%
Sole
348.87K
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares35.77K
TypeSH
Market value$9.84M
2.21%
Sole
35.77K
Shared
0.00
None
0.00
GERON CORP
SOLEShares1.80M
TypeSH
Market value$8.18M
1.84%
Sole
1.80M
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares378.75K
TypeSH
Market value$7.29M
1.64%
Sole
378.75K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares60.50K
TypeSH
Market value$6.91M
1.55%
Sole
60.50K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares574.56K
TypeSH
Market value$6.65M
1.49%
Sole
574.56K
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares146.66K
TypeSH
Market value$6.60M
1.48%
Sole
146.66K
Shared
0.00
None
0.00
C4 THERAPEUTICS INC
SOLEShares1.15M
TypeSH
Market value$6.54M
1.47%
Sole
1.15M
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares51.24K
TypeSH
Market value$6.40M
1.44%
Sole
51.24K
Shared
0.00
None
0.00
BIODESIX INC
SOLEShares3.56M
TypeSH
Market value$6.34M
1.42%
Sole
3.56M
Shared
0.00
None
0.00
ELUTIA INC
SOLEShares1.65M
TypeSH
Market value$6.27M
1.41%
Sole
1.65M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
NUVALENT INCSOLE | COM | 371.44K | SH | $38.00M 8.53% | 371.44K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 635.44K | SH | $31.75M 7.13% | 635.44K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 347.69K | SH | $25.38M 5.70% | 347.69K | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCSOLE | COM | 475.56K | SH | $21.84M 4.91% | 475.56K | 0.00 | 0.00 |
ERASCA INCSOLE | COM | 6.95M | SH | $18.96M 4.26% | 6.95M | 0.00 | 0.00 |
AKERO THERAPEUTICS INCSOLE | COM | 639.84K | SH | $18.36M 4.12% | 639.84K | 0.00 | 0.00 |
VERACYTE INCSOLE | COM | 470.56K | SH | $16.02M 3.60% | 470.56K | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCSOLE | COM | 255.58K | SH | $13.39M 3.01% | 255.58K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 1.22M | SH | $13.19M 2.96% | 1.22M | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 167.11K | SH | $12.23M 2.75% | 167.11K | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 744.59K | SH | $11.91M 2.67% | 744.59K | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 901.13K | SH | $11.44M 2.57% | 901.13K | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 1.10M | SH | $11.27M 2.53% | 1.10M | 0.00 | 0.00 |
POSEIDA THERAPEUTICS INCSOLE | COM | 3.69M | SH | $10.55M 2.37% | 3.69M | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 348.87K | SH | $10.04M 2.25% | 348.87K | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 35.77K | SH | $9.84M 2.21% | 35.77K | 0.00 | 0.00 |
GERON CORPSOLE | COM | 1.80M | SH | $8.18M 1.84% | 1.80M | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 378.75K | SH | $7.29M 1.64% | 378.75K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 60.50K | SH | $6.91M 1.55% | 60.50K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 574.56K | SH | $6.65M 1.49% | 574.56K | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 146.66K | SH | $6.60M 1.48% | 146.66K | 0.00 | 0.00 |
C4 THERAPEUTICS INCSOLE | COM STK | 1.15M | SH | $6.54M 1.47% | 1.15M | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 51.24K | SH | $6.40M 1.44% | 51.24K | 0.00 | 0.00 |
BIODESIX INCSOLE | COM | 3.56M | SH | $6.34M 1.42% | 3.56M | 0.00 | 0.00 |
ELUTIA INCSOLE | CL A COM | 1.65M | SH | $6.27M 1.41% | 1.65M | 0.00 | 0.00 |
Page 1 of 3